450 related articles for article (PubMed ID: 37651553)
1. Interventions for fatigue in people with kidney failure requiring dialysis.
Natale P; Ju A; Strippoli GF; Craig JC; Saglimbene VM; Unruh ML; Stallone G; Jaure A
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013074. PubMed ID: 37651553
[TBL] [Abstract][Full Text] [Related]
2. Interventions for improving sleep quality in people with chronic kidney disease.
Natale P; Ruospo M; Saglimbene VM; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2019 May; 5(5):CD012625. PubMed ID: 31129916
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial interventions for preventing and treating depression in dialysis patients.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
[TBL] [Abstract][Full Text] [Related]
4. Home versus in-centre haemodialysis for people with kidney failure.
Cheetham MS; Ethier I; Krishnasamy R; Cho Y; Palmer SC; Johnson DW; Craig JC; Stroumza P; Frantzen L; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD009535. PubMed ID: 38588450
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal dialysis versus haemodialysis for people commencing dialysis.
Ethier I; Hayat A; Pei J; Hawley CM; Johnson DW; Francis RS; Wong G; Craig JC; Viecelli AK; Cho Y; Htay H; Ng S; Leibowitz S
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013800. PubMed ID: 38899545
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.
Natale P; Tunnicliffe DJ; Toyama T; Palmer SC; Saglimbene VM; Ruospo M; Gargano L; Stallone G; Gesualdo L; Strippoli GF
Cochrane Database Syst Rev; 2024 May; 5(5):CD015588. PubMed ID: 38770818
[TBL] [Abstract][Full Text] [Related]
8. Complementary and alternative therapies for post-caesarean pain.
Zimpel SA; Torloni MR; Porfírio GJ; Flumignan RL; da Silva EM
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD011216. PubMed ID: 32871021
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
[TBL] [Abstract][Full Text] [Related]
10. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone antagonists for people with chronic kidney disease requiring dialysis.
Hasegawa T; Nishiwaki H; Ota E; Levack WM; Noma H
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013109. PubMed ID: 33586138
[TBL] [Abstract][Full Text] [Related]
12. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
[TBL] [Abstract][Full Text] [Related]
13. Acupuncture and related interventions for symptoms of chronic kidney disease.
Kim KH; Lee MS; Kim TH; Kang JW; Choi TY; Lee JD
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009440. PubMed ID: 27349639
[TBL] [Abstract][Full Text] [Related]
14. Exercise interventions for adults with cancer receiving radiation therapy alone.
Trommer M; Marnitz S; Skoetz N; Rupp R; Niels T; Morgenthaler J; Theurich S; von Bergwelt-Baildon M; Baues C; Baumann FT
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013448. PubMed ID: 36912791
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease.
Natale P; Palmer SC; Jaure A; Hodson EM; Ruospo M; Cooper TE; Hahn D; Saglimbene VM; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013751. PubMed ID: 36005278
[TBL] [Abstract][Full Text] [Related]
16. Carnitine supplements for people with chronic kidney disease requiring dialysis.
Nishioka N; Luo Y; Taniguchi T; Ohnishi T; Kimachi M; Ng RC; Watanabe N
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013601. PubMed ID: 36472884
[TBL] [Abstract][Full Text] [Related]
17. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Strippoli GF
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013165. PubMed ID: 32588430
[TBL] [Abstract][Full Text] [Related]
18. Low dialysate sodium levels for chronic haemodialysis.
Dunlop JL; Vandal AC; Marshall MR
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011204. PubMed ID: 30646428
[TBL] [Abstract][Full Text] [Related]
19. Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis.
Mah JY; Choy SW; Roberts MA; Desai AM; Corken M; Gwini SM; McMahon LP
Cochrane Database Syst Rev; 2020 May; 5(5):CD012616. PubMed ID: 32390133
[TBL] [Abstract][Full Text] [Related]
20. Upper limb exercise for arteriovenous fistula maturation in people requiring permanent haemodialysis access.
Nantakool S; Reanpang T; Prasannarong M; Pongtam S; Rerkasem K
Cochrane Database Syst Rev; 2022 Oct; 10(10):CD013327. PubMed ID: 36184076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
